Status:
COMPLETED
Estimating the Prevalence of Postpartum Anxiety and Depression in the Context of the Coronavirus Disease (COVID-19) Pandemic
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Depression, Postpartum
Eligibility:
FEMALE
18+ years
Brief Summary
In December 2019, infection with a new coronavirus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerged in China and has since spread throughout the world. Forms of varying severity of...
Detailed Description
Screening in these three centers is based on the use of a self-administered questionnaire for the detection of depressive disorders, the Edinburgh Postnatal Depression Scale (EPDS), which allows the c...
Eligibility Criteria
Inclusion
- Adult pregnant women delivering after 24 weeks of amenorrhea between April 6, 2020 and the end of the COVID-19 epidemic in one of the three participating maternity units
- French speaking patient
Exclusion
- Situation of fetal death or Medical Interruption of Pregnancy
- Patient under guardianship or curators
- Patient deprived of liberty
- Patient under court protection
- Patient opposing the use of his data for this research.
Key Trial Info
Start Date :
May 25 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2023
Estimated Enrollment :
2580 Patients enrolled
Trial Details
Trial ID
NCT04852757
Start Date
May 25 2021
End Date
April 30 2023
Last Update
September 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint Joseph
Paris, Île-de-France Region, France, 75014